💨 Abstract

The weight loss drug boom is influencing food industry trends, with restaurants and supermarkets offering smaller, healthier portions. Food expert Dr. Morgaine Gaye predicts that fast food chains like McDonald's and Starbucks will soon follow suit, providing smaller portions to cater to those using GLP-1 medications. These drugs not only reduce appetite but also alter taste preferences, potentially shifting consumer demand. Brands are also expected to pivot towards wellness offerings to maintain revenue as people eat less.

Courtesy: Courtney Pochin